267亿！波士顿科学完成重大收购

思宇MedTech11-18

近日，波士顿科学公司宣布完成了对医疗技术公司 Axonics 的收购。此次收购的定价为每股71美元，股权价值达到了37亿美元，折合人民币约为267.8亿人民币。波士顿科学高级副总裁兼泌尿事业部总裁 Meghan Scanlon在公告中提到，Axonics的产品组合对波士顿科学泌尿科业务至关重要，因为能帮助公司扩展到一个高增长的领域。# 收购美敦力竞争对手Axonics是一家专注于新型植入式神经调节...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484121629?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-18 19:50","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484121629","market":"us","top_or_hot":-1,"title":"267亿！波士顿科学完成重大收购","media":"思宇MedTech","content":"<div>\n<p>近日，波士顿科学公司宣布完成了对医疗技术公司 Axonics 的收购。此次收购的定价为每股71美元，股权价值达到了37亿美元，折合人民币约为267.8亿人民币。波士顿科学高级副总裁兼泌尿事业部总裁 Meghan Scanlon在公告中提到，Axonics的产品组合对波士顿科学泌尿科业务至关重要，因为能帮助公司扩展到一个高增长的领域。# 收购美敦力竞争对手Axonics是一家专注于新型植入式神经调节...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118202126a242f445&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>267亿！波士顿科学完成重大收购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n267亿！波士顿科学完成重大收购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 19:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118202126a242f445&s=b><strong>思宇MedTech</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，波士顿科学公司宣布完成了对医疗技术公司 Axonics 的收购。此次收购的定价为每股71美元，股权价值达到了37亿美元，折合人民币约为267.8亿人民币。波士顿科学高级副总裁兼泌尿事业部总裁 Meghan Scanlon在公告中提到，Axonics的产品组合对波士顿科学泌尿科业务至关重要，因为能帮助公司扩展到一个高增长的领域。# 收购美敦力竞争对手Axonics是一家专注于新型植入式神经调节...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118202126a242f445&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1291159041.SGD","symbol_name":"CPR Invest - Global Silver Age A2 Acc SGD-H","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118202126a242f445&s=b","article_id":"2484121629","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118202126a242f445&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484121629","pubTimestamp":1731930617,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，波士顿科学公司宣布完成了对医疗技术公司 Axonics 的收购。# 财务数据分析交易最初宣布时，波士顿科学公司预测 Axonics 到2023年将产生约3.36亿美元的收入，同比增长34%。2024年11月7日，Axonics公布了第三季度的财务业绩。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0251132253.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) ACC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2242649171.HKD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (HKD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","BK4581":"高盛持仓","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","BK4504":"桥水持仓","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU0238689110.USD":"贝莱德环球动力股票基金","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BSX":"波士顿科学","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0048584097.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) INC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4082":"医疗保健设备","BK4588":"碎股","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2"},"translate_title":"26.7 billion! Boston Scientific Completes Major Acquisition","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"近日，波士顿科学公司宣布完成了对医疗技术公司 Axonics 的收购。此次收购的定价为每股71美元，股权价值达到了37亿美元，折合人民币约为267.8亿人民币。波士顿科学高级副总裁兼泌尿事业部总裁 Meghan Scanlon在公告中提到，Axonics的产品组合对波士顿科学泌尿科业务至关重要，因为能帮助公司扩展到一个高增长的领域。# 收购美敦力竞争对手Axonics是一家专注于新型植入式神经调节技术的开发商，公司在骶神经调节（SNM）疗法领域取得了显著的进展。在美国，据估计，近3000万40岁及以上的成年人患有膀胱过度活动症（OAB），1900万成年人患有大便失禁。这些症状会对患者的生活质量、心理健康、睡眠、生产力和社交活动产生重大影响。之前，Axonics经过调研发现，SNM的技术难点在于电池使用寿命，此前神经刺激器的平均电池寿命只有4年，而且患者如果需要进行MRI扫描，还必须将刺激器移除。于是，Axonics推出了首款寿命长、小型、全身MRI兼容的充电式SNM系统，整个SNM领域迎来了新的里程碑。Axonics的产品组合包括Axonics R20™和Axonics F15™系统，这些系统可提供SNM疗法，用于治疗膀胱过度活动症（OAB）等，通过向骶神经发送温和的电脉冲信号，调节膀胱的神经反射，从而改善患者的生活质量。Axonics R20™Axonics R20™是公司开发的第四代可充电骶神经调节（SNM）系统。该系统已经于2023年1月得到了FDA的批准，分为四个组件：皮下植入上臀部的脉冲发生器、可充电电池、遥控器和可附着于皮肤上的无线充电器。产品特点：专有的钛陶瓷外壳：Axonics R20™系统采用了专有的钛陶瓷外壳，这种材料不仅提供了设备的耐用性，还有助于确保设备的长期稳定性和生物兼容性。体积仅5cc：Axonics R20™系统的体积非常小，仅为5cc（立方厘米），这使得植入过程更为方便，并且提高了患者的舒适度。恒定电流刺激：Axonics R20™系统提供恒定电流刺激，这意味着它能够克服阻抗变化，例如植入导丝周围的瘢痕组织形成，以确保随着时间的推移继续提供稳定的刺激。这种恒定电流刺激有助于维持适当的治疗量并减少患者调整设备的需求。快速安全充电：Axonics R20™系统具有快速充电功能，每次充电只需要一个小时，即可保证患者日常的使用。这种快速充电技术使得患者可以更便捷地管理设备，减少了日常生活中的不便。Axonics F15™Axonics F15™系统采用原电池，无需充电，在典型刺激参数下，功能寿命已验证超过15年，在较低能量设置下已验证超过20年。该系统的总尺寸为10立方厘米，比市场上其他不可充电的骶神经调节（SNM）设备小20%，使得植入过程更为方便。配备有直观、易于使用的免充电钥匙扣，采用SmartMRI™技术，方便患者进行日常控制。系统与1.5T和3.0T全身扫描仪的核磁共振成像（MRI）兼容，为患者提供了更多的诊断选项。# 财务数据分析交易最初宣布时，波士顿科学公司预测 Axonics 到2023年将产生约3.36亿美元的收入，同比增长34%。2024年11月7日，Axonics公布了第三季度的财务业绩。第三季度净收入为1.162亿美元，较上年同期增长25%。骶神经调节收入为9230万美元，较上年同期增长25%。Bulkamid 收入为 2380 万美元，比去年同期增长 25%。毛利率为 77.2%，去年同期为74.2%。截至2024年9月30日，现金、现金等价物、短期投资和限制性现金为3.67亿美元。而2024年三个季度总共的净收入达到了3.221亿美元，预计到年底将会超过3.36亿美元的目标。# 结语2024年年初，BTIG分析师Marie Thibault和Sam Eiber指出，骶神经调节市场的渗透率明显不足，这意味着市场仍有很大的增长空间。尽管美敦力在市场上占据了较大的份额，但Axonics的快速增长显示出其产品的竞争力和市场接受度。如今，收购已经完成，这次收购预计将加强波士顿科学的市场地位，并为其带来长期的增长机会，思宇将会持续关注后续发展动态。# 获奖的医疗器械公司榜单全球手术机器人行业大奖2024全球医疗技术创新奖2024全球医疗科技新锐奖2024全球创新医疗器械奖2024#海外医疗器械大厂们美敦力Medtronic｜强生J&JMedTech｜雅培Abbott｜西门子医疗Siemens Healthineers｜飞利浦Philips Medical｜史赛克Stryker｜GE医疗GE Healthcare｜波士顿科学Boston Scientific｜依视路ESSILOR｜爱尔康Alcon｜蔡司医疗Carl Zeiss#中国医疗器械大厂们迈瑞医疗Mindray｜乐普医疗Lepu Medical|微创医疗MicroPort｜威高集团Weigao|联影医疗United Imaging","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Company Corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484121629"}